Pricing

Leap Therapeutics

‌

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.

Industries

Biotechnology

Headquarters

Cambridge, United States

Employees

11-50

Links

Org chart

Douglas Onsi

President, CEO, CFO, Board Member

Collapse

Cyndi Sirard

Chief Medical Officer

Mark O'Mahony

Chief Manufacturing Officer

Gus Lawlor

Chief Operating Officer

Matthew Lederhos

Vp, Finance & Corporate Controller

Walter Newman

Senior Research Fellow

Board & advisors

Christopher Mirabelli

Chairman

Teams

Research and Scientific Team

4 people · 0 jobs

Clinical Development Team

2 people · 0 jobs

Manufacturing and Operations Team

4 people · 0 jobs

Data Management and Analysis Team

2 people · 0 jobs

Regulatory Affairs and Quality Team

0 people · 0 jobs

Leadership Team

3 people · 0 jobs

Offices

HQ
7 people · 0 jobs
JL
+3

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

170 followers

Regeneron

142 followers

Illumina

81 followers

Agilent Technologies

88 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

48 followers

GRAIL

30 followers

Cytiva

19 followers

PerkinElmer

12 followers

Explore companies